The role of water and sodium ions in the activation of the μ-opioid receptor.

Dual effect of sodium ions: The activation of G-protein-coupled receptors depends on the presence of water molecules inside the receptor and also on allosteric interactions. The binding of sodium ions to the allosteric site of the μ opioid receptor was studied by microsecond molecular dynamics simulations and their seemingly contradictory roles in preventing ligand binding and facilitating receptor activation were explained.

[1]  R. Stevens,et al.  Structure-function of the G protein-coupled receptor superfamily. , 2013, Annual review of pharmacology and toxicology.

[2]  B. Trzaskowski,et al.  The Role of Water in Activation Mechanism of Human N-Formyl Peptide Receptor 1 (FPR1) Based on Molecular Dynamics Simulations , 2012, PloS one.

[3]  Cheng Zhang,et al.  High-resolution Crystal Structure of Human Protease-activated Receptor 1 Bound to the Antagonist Vorapaxar Hhs Public Access , 2022 .

[4]  R. Stevens,et al.  Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions , 2012, Science.

[5]  V. Doze,et al.  G-Protein-Coupled Receptors in Adult Neurogenesis , 2012, Pharmacological Reviews.

[6]  L. Pardo,et al.  Crystal structure of the μ-opioid receptor bound to a morphinan antagonist , 2012, Nature.

[7]  K. Gerwert,et al.  Prediction of a ligand-binding niche within a human olfactory receptor by combining site-directed mutagenesis with dynamic homology modeling. , 2012, Angewandte Chemie.

[8]  Krzysztof Palczewski,et al.  The Significance of G Protein-Coupled Receptor Crystallography for Drug Discovery , 2011, Pharmacological Reviews.

[9]  Gianni De Fabritiis,et al.  Induced Effects of Sodium Ions on Dopaminergic G-Protein Coupled Receptors , 2010, PLoS Comput. Biol..

[10]  Slawomir Filipek,et al.  Study of a structurally similar kappa opioid receptor agonist and antagonist pair by molecular dynamics simulations , 2010, Journal of molecular modeling.

[11]  P. Scheerer,et al.  A G protein-coupled receptor at work: the rhodopsin model. , 2009, Trends in biochemical sciences.

[12]  Krzysztof Palczewski,et al.  Conserved waters mediate structural and functional activation of family A (rhodopsin-like) G protein-coupled receptors , 2009, Proceedings of the National Academy of Sciences.

[13]  M. Mayer,et al.  Selectivity and cooperativity of modulatory ions in a neurotransmitter receptor. , 2009, Biophysical journal.

[14]  H. Levine,et al.  Complex of an active mu-opioid receptor with a cyclic peptide agonist modeled from experimental constraints. , 2004, Biochemistry.

[15]  A. Christopoulos.  Allosteric binding sites on cell-surface receptors: novel targets for drug discovery , 2002, Nature Reviews Drug Discovery.

[16]  D. Selley,et al.  Effects of sodium on agonist efficacy for G‐protein activation in μ‐opioid receptor‐transfected CHO cells and rat thalamus , 2000, British journal of pharmacology.

[17]  R. DesJarlais,et al.  ASP147 in the third transmembrane helix of the rat mu opioid receptor forms ion-pairing with morphine and naltrexone. , 1999, Life sciences.

[18]  F. Medzihradsky,et al.  Regulation of μ‐Opioid Receptor in Neural Cells by Extracellular Sodium , 1997, Journal of neurochemistry.

[19]  J. Ballesteros,et al.  [19] Integrated methods for the construction of three-dimensional models and computational probing of structure-function relations in G protein-coupled receptors , 1995 .

[20]  H. Kosterlitz,et al.  Control by cations of opioid binding in guinea pig brain membranes. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[21]  B. Cox,et al.  Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes. , 1986, Molecular pharmacology.

[22]  I. Creese,et al.  Opiate receptor binding affected differentially by opiates and opioid peptides. , 1979, European journal of pharmacology.

[23]  V. Dole,et al.  Localization of d- and l-methadone after intraventricular injection into rat brains. , 1970, The Journal of pharmacology and experimental therapeutics.